The leaders driving innovation and adoption of artificial intelligence tools within the marketing and advertising industry.
Planned submission for U.S. Accelerated Approval of z-rostudirsen on track for Q2 2026; potential launch in Q1 2027 - - Positive topline results reported from Phase 1/2 DELIVER trial of z-rostudirsen ...
At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results